Respiratory Pathogen Detection

Accurate testing is essential to distinguish between respiratory pathogens

Molecular testing for respiratory pathogens helps laboratories maximize sensitivity for common viruses, including SARS-CoV-2, influenza, and RSV. Adoption of multiplex testing assays has grown over the last few years, most notably as a response to the SARS-CoV-2 pandemic. Although we have entered an endemic phase, we expect SARS-CoV-2 and its variants to remain with us indefinitely. SARS-CoV-2 now joins the list of respiratory pathogens that pathologists will see in the lab, and influenza and COVID-19 share symptoms, making differential detection even more challenging.

 

Multiplex testing assays allow laboratories to test for multiple infectious disease targets in a single reaction. This helps providers rule out multiple respiratory infections with one patient sample.

Molecular diagnostic solutions for respiratory testing

Molecular techniques including PCR-based tests are designed to enable early virus detection, even in asymptomatic cases, and help deliver reliable answers.

Applied Biosystems real-time PCR respiratory research products

Our molecular detection solutions enable the comprehensive analysis of various respiratory pathogens, encompassing viruses, bacteria, and fungi without the inherent challenges associated with immunoassay-based and culture-based techniques.

Respiratory pathogen detection resources

Gain valuable insights, tips, and best practices to enhance your understanding and proficiency in utilizing our state-of-the-art PCR technology. Our educational resources are designed to cater to both seasoned researchers and those who are new to the field, to help you achieve accurate and reliable results.

For Research Use Only. Not for use in diagnostic procedures.